Cite
MLA Citation
S. Cavalieri et al.. “Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.” European journal of cancer, vol. 97, 2018, pp. 7–15. http://access.bl.uk/ark:/81055/vdc_100065602095.0x00002e